Abstract
Objective. There is a need for patient-specific dose quantification (dosimetry) in Molecular
Radiation Therapy (MRT). Cherenkov light generated in the tissue by charged particles
produced by the radioactive decay of radiopharmaceuticals offers an unprecedented
opportunity for MRT dosimetry. While the intensity of the emitted Cherenkov light is
proportional to the dose, the intensity of light emerging and measured at the patient
surface depends on patient anatomy and tissue optical characteristics. This results in an
inter-patient variability of the linear relationship between Cherenkov light intensity at the
patient surface and the dose delivered to the tumour that hinders the implementation of
Cherenkov light-based dosimetry. A multi-patient study of Cherenkov light emission in
MRT of thyroid cancer is performed and a correction technique for the surface light
intensity is introduced to reduce this inter-patient variability.
Approach. Numerical experiments using clinical patient Computed Tomography data and
Monte Carlo simulations are performed for a set of patient anatomies and a range of
values of tissue optical parameters and tumour radioisotope uptakes, resulting in 135
treatment realisations. The impact of anatomy and tissue optical characteristics on the
characteristics of Cherenkov light is investigated. A patient-specific factor defined as the
product between the fraction of the light emitted in the tumour that emerges on the
patient surface and tumour volume and mass density is introduced to correct the intensity
of light emerging at the patient surface for the dependence on patient anatomy and tissue
optical characteristics.
Main results. There is a large inter-patient variability in the relationship between the
surface light intensity and dose delivered to the tumour. The correction technique greatly
reduces this variability and enables the derivation of a dosimetry calibration curve.
Significance. This study provides an important step towards quantitative MRT dosimetry
based on Cherenkov light emitted during treatment.